1 |
RAJASEKARAN A, JULIAN B A, RIZK D V. IgA nephropathy: an interesting autoimmune kidney disease[J]. Am J Med Sci, 2021, 361(2): 176-194.
|
2 |
GOTO M,WAKAI, KAWAMURA T,et al. A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study[J]. Nephrol Dial Transplant, 2009, 24(10): 3068-3074.
|
3 |
CAMBIER A, RABANT M, KAROUI K, et al. Clinical and histological differences between adults and children in new onset IgA nephropathy[J]. Pediatr Nephrol, 2020, 35(10): 1897-1905.
|
4 |
翟亚玲, 龙晓青, 高静歌, 等. 单纯IgA肾病与IgA肾病合并糖尿病患者循环免疫复合物的功能差异性探索研究[J]. 中国全科医学, 2020, 23(17): 2115-2119.
|
5 |
SHIMA Y, NAKANISHI K, MUKAIYAMA H, et al. Clinicopathological significance of glomerular capillary IgA deposition in childhood IgA nephropathy[J]. Pediatr Nephrol, 2021, 36(4): 899-908.
|
6 |
李晓忠, 王 震. 2012年KDIGO IgA肾病指南解读及与国内儿童IgA肾病指南比较[J]. 中华实用儿科临床杂志, 2013, 28(17): 1287-1291.
|
7 |
中华医学会儿科学分会肾脏病学组.儿童常见肾脏疾病诊治循证指南(试行)(四): 原发性IgA肾病诊断治疗指南[J]. 中华儿科杂志, 2010, 48(5): 355-357.
|
8 |
TRIMARCHI H, BARRATT J, CATTRAN D C, et al. Oxford classification of IgA nephropathy 2016: an update from the IgA nephropathy classification working group[J]. Kidney Int, 2017, 91(5): 1014-1021.
|
9 |
Writing Group of Chinese Guidelines for the Management of Hypertension, Chinese Hypertension League, Chinese Society of Cardiology, 等. 中国高血压防治指南(2018年修订版)[J]. 中国心血管杂志, 2019, 24(1): 24-56.
|
10 |
MIAN A N, SCHWARTZ G J. Measurement and estimation of glomerular filtration rate in children[J]. Adv Chronic Kidney Dis, 2017, 24(6): 348-356.
|
11 |
CHI X H, LI G P, WANG Q S, et al. CKD-EPI creatinine-cystatin C glomerular filtration rate estimation equation seems more suitable for Chinese patients with chronic kidney disease than other equations[J]. BMC Nephrol, 2017, 18(1): 226.
|
12 |
BARBOUR S J, COPPO R, ER L,et al. Updating the international IgA nephropathy prediction tool for use in children[J]. Kidney Int, 2021, 99(6): 1439-1450.
|
13 |
IMAI E, USUI J, KANEKO S, et al. The precise long-term outcomes of adult IgA nephropathy by mail questionnaires: better renal survival compared to earlier cohort studies[J]. PLoS One, 2020, 15(5): e0233186.
|
14 |
WANG T Z, YE F, MENG H X, et al. Comparison of clinicopathological features between children and adults with IgA nephropathy[J]. Pediatr Nephrol, 2012, 27(8): 1293-1300.
|
15 |
RODRIGUES J C, HAAS M, REICH H N. IgA nephropathy[J]. Clin J Am Soc Nephrol, 2017, 12(4): 677-686.
|
16 |
COPPO R. Clinical and histological risk factors for progression of IgA nephropathy: an update in children, young and adult patients[J]. J Nephrol, 2017, 30(3): 339-346.
|
17 |
WORKING GROUP OF THE INTERNATIONAL IGA NEPHROPATHY NETWORK AND THE RENAL PATHOLOGY SOCIETY, COPPO R, TROYANOV S, et al. The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults[J]. Kidney Int, 2010, 77(10): 921-927.
|
18 |
伍巧源, 李 洁, 黄 莉, 等. IgA肾病不同年龄组临床与病理特点分析[J]. 实用医学杂志, 2010, 26(18): 3374-3376.
|
19 |
王羽晴, 朱 琳, 周 萍. 黑龙江省单中心785例儿童肾活检病理分析(2002年~2019年)[J]. 肾脏病与透析肾移植杂志, 2020, 29(4): 323-327.
|
20 |
MIZERSKA-WASIAK M, TURCZYN A, SUCH A, et al. IgA nephropathy in children: a multicenter study in Poland[J]. Adv Exp Med Biol, 2016, 952: 75-84.
|
21 |
朱 迪, 祝雪妍, 罗 钢. 孤立性血尿儿童血尿类型与肾脏病理类型的关系[J]. 中国医科大学学报, 2020, 49(8): 722-726.
|
22 |
鲍 毓, 沈辉君, 路智红, 等. 单中心原发性儿童IgA肾病临床及病理特征分析(附303例报告)[J]. 中国实用儿科杂志, 2020, 35(8): 620-625.
|
23 |
赵 洁, 范秋灵, 刘 楠, 等. IgA肾病Lee分级的危险因素分析[J]. 中国医科大学学报, 2010, 39(7): 570-571.
|
24 |
WORKING GROUP OF INTERNATIONAL IGA NEPHROPATHY NETWORK AND THE RENAL PATHOLOGY SOCIETY, ROBERTS I S, COOK H T, et al. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility[J]. Kidney Int, 2009, 76(5): 546-556.
|
25 |
DELBET J D, GESLAIN G, AUGER M, et al. Histological prognostic factors in children with Henoch-Schönlein purpura nephritis[J].Pediatr Nephrol,2020,35(2):313-320.
|
26 |
SHIMA Y, NAKANISHI K, HAMA T, et al. Biopsy timing and Oxford classification variables in childhood/adolescent IgA nephropathy[J]. Pediatr Nephrol, 2015, 30(2): 293-299.
|
27 |
AI Z, ZHOU Q, HUANG F X, et al. Long-term renal outcomes of IgA nephropathy presenting with different levels of proteinuria[J]. Clin Nephrol, 2020, 94(6): 290-296.
|
28 |
娄 岩, 高 丹, 于艳波, 等. 不同水平蛋白尿的IgA肾病临床病理特点研究[J]. 中国实验诊断学, 2019, 23(9): 1654-1656.
|
29 |
MERINO G E, BORREGO U F J, GARCÍA C M J. IgA nephropathy: short term effects of prednisone treatment on proteinuria, renal function and relation with Oxford classification[J].Nefrologia, 2021,41(1): 71-74.
|
30 |
MEDJERAL-THOMAS N R, COOK H T, PICKERING M C. Complement activation in IgA nephropathy[J]. Semin Immunopathol, 2021, 43(5): 679-690.
|
31 |
PENG S Q, LU W, JIANG X, et al. IgG deposits in the mesangium and capillary loops predict poor renal outcome in patients with IgA nephropathy: a single-center retrospective study[J]. Ren Fail, 2020, 42(1): 902-911.
|
32 |
彭晓杰, 傅 睿, 郑卫民, 等. 儿童原发性IgA肾病临床表现与免疫荧光的相关性分析[J]. 中华实用儿科临床杂志, 2020, 35(17): 1329-1335.
|
33 |
WU J L, HU Z Z, WANG Y X, et al. Severe glomerular C3 deposition indicates severe renal lesions and a poor prognosis in patients with immunoglobulin A nephropathy[J]. Histopathology, 2021,78(6): 882-895.
|
34 |
徐婉梅. IgA肾病临床表现与肾脏超微结构关系的横断面研究[D]. 南宁: 广西医科大学, 2016.
|